Structure-based design of peptide inhibitors of botulinum neurotoxin serotype A proteolytic activity
by Matthew L. Ludivico, Leonard A. Smith, S. Ashraf Ahmed
The Botulinum J. (TBJ), Vol. 1, No. 3, 2009

Abstract: P1'arginine of the substrate SNAP-25 is an absolute requirement for catalysis, and the active site of botulinum neurotoxin serotype A (BoNT/A) is populated by acidic residues. We reasoned that arginine derivatives, and basic peptides might bind to the proteolytic domain, and act as inhibitors. A systematic investigation of amino acids, derivatives and basic peptides provided proofs of our concept. D-arginine, arginine hydroxamate and basic peptides effectively inhibited BoNT/A activity. Optimisation of the peptide inhibitors resulted in a RRGC tetrapeptide displaying 90% inhibition at 20 microM. Our studies provide an inhibitor scaffold for potential development as a BoNT/A drug candidate.

Online publication date: Wed, 17-Feb-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the The Botulinum J. (TBJ):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com